Statistical methods for cost-effectiveness analyses

被引:26
作者
Siegel, C [1 ]
Laska, E [1 ]
Meisner, M [1 ]
机构
[1] NYU,SCH MED,DEPT PSYCHIAT,NEW YORK,NY 10012
来源
CONTROLLED CLINICAL TRIALS | 1996年 / 17卷 / 05期
关键词
preference measures; cost-benefit; net benefit; cost effectiveness ratio; benefit; cost utility; non-responder models;
D O I
10.1016/S0197-2456(95)00259-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A statistical framework is presented for examining cost and effect data on competing interventions obtained from an RCT or from an observational study. Parameters of the joint distribution of costs and effects or a regression function linking costs and effects are used to define cost-effectiveness (c-e) measures. Several new c-e measures are proposed that utilize the linkage between costs and effects on the patient level. These measures reflect perspectives that are different from those of the commonly used measures, such as the ratio of expected cost to expected effect, and they can lead to different relative rankings of the interventions. The cost-effectiveness of interventions are assessed statistically in a two stage procedure that first eliminates clearly inferior interventions. Members of the remaining admissible set are then rank ordered according to a c-e preference measure. Statistical techniques, particularly in the multivariate normal case, are given for several commonly used c-e measures. These techniques provide methods for obtaining confidence intervals, for testing the hypothesis of admissibility and for the equality of interventions, and for ranking interventions. The ideas are illustrated for a hypothetical clinical trial of antipsychotic agents for community-based persons with mental illness. (C) Elsevier Science Inc.
引用
收藏
页码:387 / 406
页数:20
相关论文
共 33 条
[1]   ECONOMIC-ANALYSIS IN RANDOMIZED CONTROL TRIALS [J].
ADAMS, ME ;
MCCALL, NT ;
GRAY, DT ;
ORZA, MJ ;
CHALMERS, TC .
MEDICAL CARE, 1992, 30 (03) :231-243
[2]  
Culyer A J, 1992, Health Econ, V1, P7, DOI 10.1002/hec.4730010105
[3]   A MULTIVARIATE SOLUTION OF THE MULTIVARIATE RANKING AND SELECTION PROBLEM [J].
DUDEWICZ, EJ ;
TANEJA, VS .
COMMUNICATIONS IN STATISTICS PART A-THEORY AND METHODS, 1981, 10 (18) :1849-1868
[4]   APPLYING COST-EFFECTIVENESS ANALYSIS - THE INSIDE STORY [J].
EDDY, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (18) :2575-2582
[5]   THE USE OF MIXTURE-MODELS FOR THE ANALYSIS OF SURVIVAL-DATA WITH LONG-TERM SURVIVORS [J].
FAREWELL, VT .
BIOMETRICS, 1982, 38 (04) :1041-1046
[6]   A COMPETING RISKS DERIVATION OF A MIXTURE MODEL FOR THE ANALYSIS OF SURVIVAL-DATA [J].
GREENHOUSE, JB ;
WOLFE, RA .
COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1984, 13 (25) :3133-3154
[7]  
JERRELL JM, 1989, INQUIRY-J HEALTH CAR, V26, P224
[8]   COST-UTILITY ANALYSIS OF MAINTENANCE TREATMENT FOR RECURRENT DEPRESSION [J].
KAMLET, MS ;
PAUL, N ;
GREENHOUSE, J ;
KUPFER, D ;
FRANK, E ;
WADE, M .
CONTROLLED CLINICAL TRIALS, 1995, 16 (01) :17-40
[9]  
KEENEY R. L., 1976, Decision with Multiple Objectives: Preferences and value tradeoffs
[10]   ONSET AND DURATION - MEASUREMENT AND ANALYSIS [J].
LASKA, EM ;
SIEGEL, C ;
SUNSHINE, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (01) :1-5